| 名稱 | MCF7-Luc示蹤細(xì)胞株 |
| 型號 | CBP30105L |
| 報(bào)價(jià) |  |
| 特點(diǎn) | MCF7-Luc示蹤細(xì)胞株，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 科學(xué)家如何深度破解癌癥基因組的奧秘？
- 【連載-企業(yè)參考品】 神經(jīng)膠質(zhì)瘤的診斷參考品的選擇
- GLP1R藥靶篩選模型應(yīng)用展示
- 羅氏免疫療法獲FDA批準(zhǔn)治療晚期非小細(xì)胞肺癌（NSCLC）
- 細(xì)胞株的代謝產(chǎn)物分析
- GPR52——神經(jīng)治療潛在靶點(diǎn)
- ATCC細(xì)胞系的細(xì)胞培養(yǎng)步驟
- IL36靶點(diǎn)藥物細(xì)胞篩選模型藥
- 老靶點(diǎn)迭代突破創(chuàng)新：Her2靶點(diǎn)細(xì)胞模型
- PNAS：腫瘤細(xì)胞或可“拆用”間充質(zhì)干細(xì)胞來促進(jìn)乳腺癌復(fù)發(fā)
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
電話：4008750250
號碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
> 示蹤細(xì)胞株 > CBP30105LMCF7-Luc示蹤細(xì)胞株
- 詳細(xì)內(nèi)容
| CBP30105L | |
| I. Introduction | |
| Host Cell: | MCF7(ER positive) |
| Expressed gene: | Luciferase |
| Stability: | 32 passages(in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | MEM + 10% FBS+ 1% Non Essential Amino Acids (NEAA) + 1mM Sodium Pyruvate (NaP)+ 10 µg/ml human insulin+ 1ug/ml puromycin |
| Mycoplasma Status: | Negative |
| Storage: | Liquid nitrogen |
| II. Description of Host Cell Line | |
| Organism: | Homo sapiens, human |
| Tissue: | Mammary gland/breast; derived from metastatic site: pleural effusion |
| Disease: | Adenocarcinoma |
| Morphology: | Epithelial |
| Growth Properties: | Adherent |
| III. Representative Data | |
| |
Figure 1. Detect Luciferase assay by Promega Bright-Glo Luciferase Assay System. | |
| IV. Stablity Test | |
 | |
Figure 2. Stablity test results. MCF7-Luc cells showed at least 32 passage stability with similar luminescence unit. | |
